Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: Safety, Tolerability and Effects of Mannitol in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, tolerability, and effects of mannitol in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mannitol (mannitol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN